A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Phase 1/2 Unknown
260 enrolled
ParaSOL
Phase 2/3 Unknown
100 enrolled
Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors
Phase 1 Unknown
50 enrolled
A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)
Phase 2 Unknown
50 enrolled
TPVB
Phase NA Unknown
68 enrolled
Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers
Unknown
40 enrolled
A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression
Phase 3 Unknown
351 enrolled
A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer
Phase 2 Unknown
57 enrolled
A Study of RC48-ADC for the Treatment of HER2-expressing Gynecological Malignancies
Phase 2 Unknown
120 enrolled
Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Phase 1 Unknown
75 enrolled
A Study of RC98 in Subjects With Advanced Malignant Solid Tumors
Phase 1 Unknown
63 enrolled
Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors
Phase 1 Unknown
100 enrolled
A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors
Phase 1 Unknown
135 enrolled
DTC
Phase 2 Unknown
120 enrolled
Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects
Phase 2 Unknown
128 enrolled
Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors
Phase 1 Unknown
10 enrolled
A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection
Phase NA Unknown
36 enrolled
Pediatric_PK
Phase 1 Unknown
21 enrolled
A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors
Phase 1/2 Unknown
281 enrolled
A Study of 7MW3711 in Subjects With Advanced Solid Tumors
Phase 1/2 Unknown
164 enrolled
Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy
Phase 1 Unknown
48 enrolled
FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer
Phase 3 Unknown
314 enrolled
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma
Phase 2 Unknown
21 enrolled
A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.
Phase 1/2 Unknown
116 enrolled
BC3195
Phase 1 Unknown
27 enrolled
Clinical Trial Evaluating the Safety of the TQB2103 for Injection
Phase 1 Unknown
71 enrolled
FLICOR
Phase NA Unknown
50 enrolled
Depo-Trigger
Phase 1/2 Unknown
30 enrolled
Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg
Phase 1 Unknown
24 enrolled
Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study
Phase 2 Unknown
50 enrolled
A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)
Phase 3 Unknown
489 enrolled
Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MM
Phase 1 Unknown
24 enrolled
GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Phase NA Unknown
20 enrolled
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors
Phase 2 Unknown
60 enrolled
Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors
Phase 1 Unknown
50 enrolled
Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC
Phase 2 Unknown
28 enrolled
A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer
Phase 2 Unknown
53 enrolled
A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer
Phase 2/3 Unknown
350 enrolled
COSEFDIP
Phase NA Unknown
3,000 enrolled
A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)
Phase 3 Unknown
454 enrolled
A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer
Phase 1/2 Unknown
48 enrolled
POLA
Phase NA Unknown
190 enrolled
A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer
Phase 2 Unknown
100 enrolled
Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma
Phase 2/3 Unknown
216 enrolled
A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients
Phase 2 Unknown
64 enrolled
A Study of Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)
Phase 1/2 Unknown
54 enrolled
A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer
Phase 2 Unknown
63 enrolled
Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009
Phase 1 Unknown
48 enrolled
A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer
Phase 2 Unknown
94 enrolled
Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy
Phase NA Unknown
50 enrolled